Crestal vs Lateral Sinus Lift Augmentation

September 29, 2019 updated by: Marco Tallarico, Hospital San Pietro Fatebenefratelli

Crestal Versus Lateral Sinus Lift: One-year Results From a Within-patient Randomised Controlled Trial

The aim of this randomised controlled trial (RCT) of split-mouth design was to compare patient preference and effectiveness of two different techniques for lifting the maxillary sinus: the crestal approach versus the lateral window approach.

Study Overview

Detailed Description

Each patient having bilateral edentulism in posterior maxillae was randomised to receive one partial fixed prosthesis supported by one to three implants placed either with a crestal or with lateral window sinus lift procedure.

Eligibility criteria for participants

Only healed implant sites were considered (at least 3 months after tooth extraction). The vertical bone height at the implant sites to be included had to be between 2 to 6 mm and bone thickness at least 6 mm as measured on cone-bean computed tomography (CBCT) scans.

Patients were not admitted in the study if any of the following exclusion criteria was present:

general contraindications to implant surgery subjected to irradiation in the head and neck area immunosuppressed or immunocompromised treated or under treatment with intravenous amino-bisphosphonates poor oral hygiene and motivation untreated periodontal disease uncontrolled diabetes pregnant or lactating substance abusers psychiatric problems unrealistic expectations lack of opposite occluding dentition/prosthesis in the area intended for implant placement acute or chronic infection/inflammation in the area intended for sinus augmentation/implant placement referred only for implant placement who cannot be rehabilitated and followed at the treatment centre unable to attend a 5-year post-loading follow-up. Smokers were included and patients were categorised into three groups according to what declare: i) non-smokers; ìì) moderate smokers, if smoking up to 10 cigarettes/day; iii) heavy smokers if smoking more than 10 cigarettes/day.

Patients were recruited and treated in one private practice in Tirana, Albania by two operators: Marco Tallarico who performed all surgical interventions and Erta Xhanari who performed all prosthetic and maintenance procedures.

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tirana, Albania
        • Aldent University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Partially edentulous patient
  • Bilateral edentulism in posterior maxillae (premolars and molars)
  • 18 years or older
  • Able to understand and sign an informed consent.
  • At least 3 months after tooth extraction
  • Vertical bone height at the implant sites between 2 to 6 mm
  • Bone thickness at least 6 mm as measured on CBCT scan

Exclusion Criteria:

  • general contraindications to implant surgery
  • subjected to irradiation in the head and neck area
  • immunosuppressed or immunocompromised
  • treated or under treatment with intravenous amino-bisphosphonates
  • poor oral hygiene and motivation
  • untreated periodontal disease
  • uncontrolled diabetes
  • pregnant or lactating
  • substance abusers
  • psychiatric problems
  • unrealistic expectations
  • lack of opposite occluding dentition/prosthesis
  • acute or chronic infection/inflammation
  • augmentation/implant placement
  • referred only for implant placement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Crestal sinus lift using iRasie implant

Device: iRaise Sinus Lift implant (Maxillent, Herzliya, Israel). Procedure: crestal sinus lift augmentation.

We tested crestal versus lateral approach to the sinus. Crestal approach is made by a novel device (iRaise, implant system). Lateral approach is made conventionally with gold standard procedure (lateral approach).

The iRaise Sinus Lift implant is made of Titanium-6 Aluminum-4 Vanadium alloy, have a surface treated with grit blasting using an apatitic calcium phosphate media, followed by acid etching, and have an internal hexagon connection. Implants have an internal l-shape channel to allow saline and graft passage.

This implants system is made to perform crestal sinus lift procedure at the same time of the implant placement using the same device. After implant site preparation and initial implant placement, the hydraulic system is connected to the implant to allow the injection of saline and then graft the material. Then, the implant, is inserted for its full length.

Raise the sinus membrane to graft bone substitute to augment the sinus cavity allowing implants placement.
Other Names:
  • Sinus lift
ACTIVE_COMPARATOR: Lateral sinus lift

Conventional procedure.

Lateral approach to the sinus was made following the conventional procedure.

A window on the lateral wall of the sinus is performed according to a conventional surgical lateral approach to the sinus cavity. Graft materials is filled inside the sinus cavity. Finally, iSure implants [Maxillent] are placed, and flap is sutured.

Raise the sinus membrane to graft bone substitute to augment the sinus cavity allowing implants placement.
Other Names:
  • Sinus lift

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prosthesis failure
Time Frame: Up to 5 years
Planned prosthesis which could not be placed due to implant failure(s), loss of the prosthesis secondary to implant failure(s) or a prosthesis that had to be remade for any reasons.
Up to 5 years
Implant failure
Time Frame: Up to 5 years
Implant mobility, removal of stable implants dictated by progressive marginal bone loss or infection, and implants fracture or any other mechanical complications rendering the implant unusable. The stability of each individual implant was measured with the removed prosthesis at abutment connection, at delivery definitive prostheses and at 1 year after loading, by tightening the implant abutment screws with a torque of 20 Ncm or by assessing the stability of individual crowns using the handles of two metallic instruments.
Up to 5 years
Complications
Time Frame: Up to 5 years
Any technical and biological complications
Up to 5 years
Patient's preference (questionnaire)
Time Frame: Assessed 1 week and 1 month after surgery
Answers: 1) the side treated with the crestal technique, 2) the side treated with the lateral technique, 3) none, both treatments were equally good, 4) none, both treatments were equally bad.
Assessed 1 week and 1 month after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time (minutes)
Time Frame: The time in minutes of the surgical procedure, from the incision of the gingiva to the placement of the last stitch
Time needs to perform the procedure, starting from the surgical incision to the delivery of the last suture, including the additional implants.
The time in minutes of the surgical procedure, from the incision of the gingiva to the placement of the last stitch
Marginal bone loss
Time Frame: 1 year after loading
Assessed on digital periapical radiographs taken with the paralleling technique at implant placement, prosthesis delivery and 1 year after loading using a digital apparatus (CS 2100, Carestream Dental, Rochester, NY, US). In the case of a not properly readable radiograph, the radiograph was to be taken again. Radiographs were stored in a TIFF format with a 600 dpi resolution, in a personal computer. Peri-implant marginal bone levels were measured using the DFW 2.8 software for windows (Soredex, Tuusula, Finland). The software was calibrated for every single image using the known implant diameter. The distance between marginal bone level and implant/abutment junction, was measured at both mesial and distal sides to the nearest 0.01 mm and averaged. Bone level changes at single implants was averaged at sinus level and then at group level. Reference points for the linear measurements were: the coronal margin of the implant collar and the most coronal point of bone-to-implant contact.
1 year after loading

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 1, 2015

Primary Completion (ACTUAL)

March 30, 2018

Study Completion (ACTUAL)

April 2, 2019

Study Registration Dates

First Submitted

June 16, 2019

First Submitted That Met QC Criteria

September 29, 2019

First Posted (ACTUAL)

October 1, 2019

Study Record Updates

Last Update Posted (ACTUAL)

October 1, 2019

Last Update Submitted That Met QC Criteria

September 29, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Edentulous Alveolar Ridge

Clinical Trials on Maxillary sinus augmentation

3
Subscribe